TREM2 and central nervous system disorder: Their identification could provide new targets for the development of potential therapeutic strategies, such as the use of TREM2 agonists to alleviate neuroinflammation in microglia cells and treat CNS disorders associated with M1 activation and polarization of microglia cells.